Micropump market seen reaching $4.85 billion by 2030

The Business Research Company says the micropump market will grow from $2.32 billion in 2025 to $4.85 billion by 2030, expanding at a 15.9% CAGR. Demand from cardiovascular care, precision drug delivery and smart medical devices is driving the outlook, with North America leading in 2025 and Europe set to grow fastest.

Why it matters: - Micropumps are becoming more important in medical and pharmaceutical systems that need precise, small-volume fluid control. - The market's growth points to rising demand for minimally invasive devices, point-of-care diagnostics and wearable drug delivery. - The outlook also signals stronger adoption of microfluidics, automation and smart healthcare hardware.

What happened: - The Business Research Company projected the micropump market will rise from $2.32 billion in 2025 to $2.69 billion in 2026. - The same report forecasts the market will reach $4.85 billion by 2030. - The company said the market will expand at a 15.9% CAGR across the forecast period. - The report was released Aug. 18, 2026, from London. - The company published a free sample report and a full market report.

The details: - Micropumps are compact devices that transport very small fluid volumes, typically from microliters to milliliters. - The devices are used in medical devices, drug delivery systems and microfluidic technology. - Growth through 2026 was driven by demand for minimally invasive medical devices, microfluidic advances, pharmaceutical research and clinical trials, point-of-care diagnostics and early-stage drug delivery systems. - Future growth is expected to come from AI and IoT integration, precision medicine, wearable drug delivery devices, automated laboratory instruments and smart microfluidic platforms. - Key trends include miniaturized fluid control systems, high-precision drug delivery, lab-on-a-chip integration, low-power micropumps and modular designs. - Cardiovascular disease is a major demand driver because micropumps can deliver anticoagulants and antihypertensives with continuous precision. - The American Heart Association reported in January 2024 that the age-adjusted U.S. death rate from cardiovascular disease rose to 233.3 per 100,000 in 2023 from 224.4 the year before. - North America held the largest market share in 2025. - Europe is projected to be the fastest-growing region during the forecast period. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report update includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables.

Between the lines: - The market forecast suggests micropumps are moving from niche components to core enabling technology in connected and precision medicine systems. - The focus on AI, IoT and automation indicates buyers want devices that fit into digital workflows, not just standalone pumps. - The regional split suggests mature healthcare systems are driving current revenue, while Europe's innovation push may shape near-term growth.

What's next: - The report expects demand to keep rising as precision medicine, wearable delivery systems and lab automation expand. - Micropump makers will likely compete on power efficiency, modularity and tighter integration with digital platforms. - Regional growth patterns will likely stay tied to healthcare investment and adoption of advanced medical technologies.

The bottom line: - Micropumps are set for sustained double-digit growth as healthcare shifts toward precision delivery, connected devices and micro-scale fluid control.